The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
| Summaries of Product Characteristics 61 - 90 of 210 |
|
|
|
Package
leaflet | Status for
supply | Name of the medicinal product |
|
|
|
European Medicines Agency's website:
NeoRecormon - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Neotigason 10 mg, 25 mg kapseli, kova SPC 2024-07-24
|
|
|
|
European Medicines Agency's website:
Neparvis - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Nepexto - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Nephromag 0,2 mg valmisteyhdistelmä radioaktiivista lääkettä varten SPC 2022-02-09
|
|
|
|
European Medicines Agency's website:
Nerlynx - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Neulactil 10 mg tabletti SPC 2012-03-14
|
|
|
|
European Medicines Agency's website:
Neulasta - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Neupogen 0,3 mg-ml injektioneste SPC 2024-03-05
|
|
|
|
European Medicines Agency's website:
Neupro - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Neuraceq - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Neuramin 50 mg-ml injektioneste, liuos SPC 2023-02-02
|
|
PL
|
Itsehoito
|
Neurobion forte tabletti, päällystetty SPC 2022-01-22
|
|
PL
|
Itsehoito
|
NeuroMax forte tabletti, kalvopäällysteinen SPC 2022-01-04
|
|
PL
|
Resepti
|
Neurontin 300 mg, 400 mg kapseli, kova SPC 2024-02-15
|
|
PL
|
Resepti
|
Neurontin 600 mg, 800 mg tabletti, kalvopäällysteinen SPC 2024-02-15
|
|
PL
|
Resepti
|
Neurotol slow 100 mg, 200 mg, 300 mg tabletti SPC 2022-01-31
|
|
|
|
European Medicines Agency's website:
Nevanac - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Nevirapine Viatris 400 mg depottabletti SPC 2024-03-28
|
|
|
|
European Medicines Agency's website:
Nexavar - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Nexium 10 mg enterorakeet oraalisuspensiota varten, annospussi SPC 2022-06-02
|
|
PL
|
Resepti
|
Nexium 20 mg, 40 mg enterotabletti SPC 2022-06-02
|
|
PL
|
Resepti
|
Nexium 40 mg injektio-infuusiokuiva-aine, liuosta varten SPC 2022-06-02
|
|
|
|
European Medicines Agency's website:
Nexium Control - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
NexoBrid - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Nexodal 0,4 mg-ml injektio-infuusioneste, liuos SPC 2022-01-20
|
|
PL
|
Resepti
|
Nexplanon 68 mg implantaatti, ihon alle SPC 2024-06-04
|
|
|
|
European Medicines Agency's website:
NEXPOVIO - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Nexviadyme - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Ngenla - EMA: EPAR PI
Finnish Swedish
|
|
|
